Alterity Therapeutics Limited (ADR) (ATHE) Live Share Price, Invest From India

Alterity Therapeutics Limited (ADR) Stock Performance

as on July 11, 2026 at 2:16 pm IST

Day's Low
Day's High
$5.38
Day's Price Range
$5.54
$5.43
0.92%
Downside
2.03%
Upside
52 Week's Low
52 Week's High
$2.66
52-Week Price Range
$7.00
$5.43
51.01%
Downside
28.91%
Upside

Alterity Therapeutics Limited (ADR) share price movements today

Previous Close: $5.38
Open: $5.47
Volume: 99.3K
Day's Low - High: $5.38 - $5.54
52 Week Low - High: $2.66 - $7.00

Alterity Therapeutics Limited (ADR) Historical Returns

1 Month Return: + 32.12 %
3 Month Return: + 46.16 %
1 Year Return: + 18.3 %
3 Year Return: + 93.24 %
5 Year Return: -67.68 %

Alterity Therapeutics Limited (ADR) Stock Fundamentals & Key Indicators

Check Alterity Therapeutics Limited (ADR) market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$98.4M

EPS (TTM)

-0.87

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

-47.03%

Alterity Therapeutics Limited (ADR) vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Alterity Therapeutics Limited (ADR) with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Alterity Therapeutics Limited (ADR)	NA	$98.4M	-67.68%	NA	-219.85%	NA
Alnylam Pharmaceuticals Inc.	BUY	$41.8B	69.04%	81.24	12.55%	NA
Vertex Pharmaceuticals Inc.	BUY	$126.0B	144.95%	29.59	35.51%	NA
Regeneron Pharmaceuticals Inc.	BUY	$70.0B	14.49%	16.18	29.65%	0.54%

Stock Returns calculator for Alterity Therapeutics Limited (ADR) Stock including INR - Dollar returns

The Alterity Therapeutics Limited (ADR) stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Alterity Therapeutics Limited (ADR) investment value today

Current value as on today

₹1,31,604

Returns

₹31,604

(+31.6%)

Returns from Alterity Therapeutics Limited (ADR) Stock

₹18,301 (+18.3%)

Dollar Impact

₹13,303 (+13.3%)

Indian Investors' Interest in Alterity Therapeutics Limited (ADR) Stock

Search interest for Alterity Therapeutics Limited (ADR) Stock has increased by 157% in the last 30 days, reflecting an upward trend in search activity.

Time period: June 11, 2026 to July 11, 2026

Change:157% versus previous 30 day period

Alterity Therapeutics Limited (ADR) Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Jun 2025
Total Revenue	0	1	0	1	1	2	0	1	3
Gross Profit	0	0	0	1	1	2	0	1	3
Operating Income	-3	-7	-3	-4	-6	-12	-3	-7	-7
EBITDA	-3	-7	-3	-8	-6	-14	-3	-7	-7
Interest Expense	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-
Income Before Tax	-2	-7	-3	-4	-6	-14	-3	-8	-4
Income Tax Expense	0	-1	-	-1	0	-2	-	-1	0
Net Income	-1	-3	-3	-6	-6	-12	-3	-7	-4
Net Profit Margin	-377.30%	-377.30%	-342.35%	-342.35%	-595.51%	-595.51%	-446.68%	-446.68%	-129.78%

Alterity Therapeutics Limited (ADR) Annual Profit & Loss

All numbers in Millions USD

	Jun 2016	Jun 2017	Jun 2018	Jun 2019	Jun 2020	Jun 2021	Jun 2022	Jun 2023	Jun 2024	Jun 2025
Total Revenue	0	0	0	0	0	3	3	2	2	5
Gross Profit	0	0	0	0	0	3	3	2	2	5
Operating Income	-8	-6	-7	-12	-10	-15	-15	-14	-19	-14
EBITDA	-8	-6	-11	-12	-13	-15	-17	-14	-19	-14
Interest Expense	-	-	-	-	-	-	0	-	-	-
Depreciation	-	0	0	0	0	0	0	0	0	0
Income Before Tax	-7	-7	-8	-12	-10	-15	-12	-13	-19	-12
Income Tax Expense	0	0	0	0	0	-3	0	0	0	0
Net Income	-5	-5	-6	-8	-6	-11	-9	-9	-12	-12
Net Profit Margin	-5418.28%	-5696.60%	-4108.75%	-11020.84%	-2444.24%	-352.78%	-250.75%	-352.54%	-475.79%	-223.35%

Alterity Therapeutics Limited (ADR) Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Dec 2025	Mar 2026
Net Income	-4	-	-12	-3	-7	-	-3	-9	-
Operating Cash Flow	-4	-	-8	-4	-8	-	-2	-10	-
Investing Cash Flow	0	-	0	-	-	-	-7	7	-
Financing Cash Flow	0	8	8	0	0	14	25	18	0
Change in Cash	-4	5	0	-	-4	-	15	16	-

Alterity Therapeutics Limited (ADR) Annual Cash Flow

All numbers in Millions USD

	Jun 2017	Jun 2018	Jun 2019	Jun 2020	Jun 2021	Jun 2022	Jun 2023	Jun 2024	Jun 2025
Net Income	-7	-8	-12	-10	-15	-12	-13	-19	-12
Operating Cash Flow	-5	-6	-13	-9	-17	-12	-20	-12	-11
Investing Cash Flow	0	0	0	0	0	0	0	0	-7
Financing Cash Flow	0	0	12	3	36	16	0	9	39
Change in Cash	-6	-6	0	-5	18	6	-19	-3	20

Global Institutional Holdings in Alterity Therapeutics Limited (ADR)

Funds	Holdings
GAMMA Investing LLC	0.01%
Motiv8 Investments LLC	0%
UBS Group AG	0%
Steward Partners Investment Advisory, LLC	0%
Ronald Blue Trust, Inc.	0%

See all

Insights on Alterity Therapeutics Limited (ADR)

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Best in 1 Year
In the last 1 year, ATHE has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Best in 3 Years
In the last 3 years, ATHE has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Price Rise
In the last 1 month, ATHE stock has moved up by 29.6%
POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 3 quarters, 802.96K → 3.83M (in $), with an average increase of 54.1% per quarter
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, -4.97M → -9.43M (in $), with an average decrease of 89.8% per quarter

About Alterity Therapeutics Limited (ADR)

Alterity Therapeutics Limited is engages in research and development of Parkinsonian and neurodegenerative disorders, including Multiple System Atrophy (MSA) and Parkinson's disease. The company's lead drug candidate is ATH434, a small molecule drug candidate that has completed Phase II clinical trial for the treatment of Parkinson's disease. It is also developing ATH434-201, which is in Phase II clinical trial to treat multiple system atrophy early stage; and ATH434-202 that is in Phase II clinical trial to treat multiple system atrophy, as well as biomarkers of progression in multiple system atrophy. The company also operates drug discovery platform that generates patentable chemical compounds to treat the underlying pathology of neurological diseases. The company was formerly known as Prana Biotechnology Limited and changed its name to Alterity Therapeutics Limited in April 2019. Alterity Therapeutics Limited was incorporated in 1997 and is based in Melbourne, Australia.

Organisation	Alterity Therapeutics Limited (ADR)
Headquarters	500 Collins Street, Melbourne, VIC, Australia, 3000
Industry	Biotechnology
CEO	Dr. David A. Stamler M.D.
E-voting on shares	Click here to vote

Key Management of Alterity Therapeutics Limited (ADR)

Name	Title
Ms. Abby Macnish Niven B.Com., B.Sc., C.F.A.	CFO & Company Secretary
Dr. Rudolph Emile Tanzi Ph.D.	Chief Scientific Advisor and Member of Research & Development Advisory Board
Dr. Steven D. Targum M.D.	Chief Medical Advisor
Dr. Robert Cherny	Head of Research
Dr. David A. Stamler M.D.	CEO & Director

FAQs

What is Alterity Therapeutics Limited (ADR) share price today?

Alterity Therapeutics Limited (ADR) share price today is $5.43 as on July 11, 2026 at 8:46 am IST at the close of the market. Alterity Therapeutics Limited (ADR) share today touched a day high of $5.54 and a low of $5.38.

What is the 52 week high and 52 week low for Alterity Therapeutics Limited (ADR) share?

Alterity Therapeutics Limited (ADR) share touched a 52 week high of $7.00 on July 25, 2025 and a 52 week low of $2.66 on December 18, 2025. Alterity Therapeutics Limited (ADR) stock price today i.e. July 11, 2026 at 8:46 am IST is closed at $5.43,which is 22.43% down from its 52 week high and 104.14% up from its 52 week low.

What is Alterity Therapeutics Limited (ADR)'s market capitalisation today?

Alterity Therapeutics Limited (ADR) market capitalisation is $0.00T as on July 11, 2026 at 8:46 am IST.

How to invest in Alterity Therapeutics Limited (ADR) Stock (ATHE) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Alterity Therapeutics Limited (ADR) on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Alterity Therapeutics Limited (ADR) Shares that will get you 0.2762 shares as per Alterity Therapeutics Limited (ADR) share price of $5.43 per share as on July 11, 2026 at 8:46 am IST.

What is the minimum amount required to buy Alterity Therapeutics Limited (ADR) Stock (ATHE) from India?

Indian investors can start investing in Alterity Therapeutics Limited (ADR) (ATHE) shares with as little as ₹95.315 or $1 (as of July 11, 2026 at 10:37 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹953.15 in Alterity Therapeutics Limited (ADR) stock (as per the Rupee-Dollar exchange rate as on July 11, 2026 at 10:37 am IST). Based on Alterity Therapeutics Limited (ADR) share’s latest price of $5.43 as on July 11, 2026 at 8:46 am IST, you will get 1.8416 shares of Alterity Therapeutics Limited (ADR). Learn more about fractional shares .

What are the returns that Alterity Therapeutics Limited (ADR) has given to Indian investors in the last 5 years?

Alterity Therapeutics Limited (ADR) stock has given -67.68% share price returns and 28.08% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?